Fingerprinting the circulating repertoire of antibodies from cancer patients

Nature Biotechnology

Volumn 21, Issue 1, 2003, Pages 57-63

  Mintz, Paul J ^a   Kim, Jeri ^a   Do, Kim Anh ^a   Wang, Xuemei ^a   Zinner, Ralph G ^a   Cristofanilli, Massimo ^a   Arap, Marco A ^a   Hong, Waun Ki ^a   Troncoso, Patricia ^a   Logothetis, Christopher J ^a   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; DIAGNOSIS; TUMORS;

PEPTIDES;

PATIENT MONITORING;

ANDROGEN; CANCER ANTIBODY; PEPTIDE; TUMOR ANTIGEN;

ARTICLE; BACTERIOPHAGE; BLOOD DONOR; CANCER GROWTH; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN MOTIF; PROTEIN PURIFICATION; VALIDATION PROCESS;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; HUMANS; MALE; PEPTIDE LIBRARY; PROSTATIC NEOPLASMS; RECEPTORS, NEUROPEPTIDE; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 12244296118     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt774     Document Type: Article

References (49)

1. Smith, G.P. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1317 (1985).
2. Brown, K.C. New approaches for cell-specific targeting: Identification of cell-selective peptides from combinatorial libraries. Curr. Opin. Chem. Biol. 4, 16-20 (2000).
3. Phage Display: A Laboratory Manual (eds. Barbas, C.F. III, Burton, D.R., Scott, J.K. & Silverman, G.J.; Cold Spring Harbor Laboratory Press, New York, NY, 2000).
4. Kolonin, M., Pasqualini, R. & Arap, W. Molecular addresses in blood vessels as targets for therapy. Curr. Opin. Chem. Biol. 5, 308-313 (2001).
5. Giordano, R.J., Cardó-Vila, M., Lahdenranta, J., Pasqualini, R. & Arap, W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7, 1249-1253 (2001).
6. Scott, J.K. & Smith, G.P. Searching for peptide ligands with an epitope library. Science 249, 386-390 (1990).
7. Smith, G.P. & Scott, J.K. Libraries of peptides and proteins displayed on filamentous phage. Meth. Enzymol. 217, 228-257 (1993).
8. Boon, T. & Old, L.J. Cancer tumor antigens. Curr. Opin. Immunol. 9, 681-683 (1997).
9. Rosenberg, S.A. Progress in human tumour immunology and immunotherapy. Nature 411, 380-384 (2001).
10. Smyth, M.J., Godfrey, D.I. & Trapani, J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2, 293-299 (2001).
11. Kaplan, E.L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53, 457-481 (1958).
12. Ganglberger, E. et al. Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. FASEB J. 14, 2177-2184 (2000).
13. Buhl, L., Szecsi, P.B., Gisselo, G.G. & Schafer-Nielsen, C. Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia. Br. J. Haematol. 116, 549-554 (2002).
14. Suphioglu C. et al. A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction. FEBS Lett. 502, 46-52 (2001).
15. Suphioglu C. et al. A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction. FEBS Lett. 502, 46-52 (2001).
16. Feige, U. & Polla, B.S. Hsp70 - a multi-gene, multi-structure, multi-function family with potential clinical applications. Experientia 50, 979-986 (1994).
17. Melnick, J. & Argon, Y. Molecular chaperones and the biosynthesis of antigen receptors. Immunol. Today 16, 243-250 (1995).
18. Lee, A.S. The glucose-regulated proteins: Stress induction and clinical applications. Trends Biochem. Sci. 26, 504-510 (2001).
19. Brown, J.M. & Giaccia, A.J. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408-1416 (1998).
20. Bicknell, R., Lewis, C.E. & Ferrara, N. (eds.) Tumour Angiogenesis (Oxford University Press, Oxford, 1997).
21. Alaiya, A.A. et al. Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol. Life Sci. 58, 307-311 (2001).
22. Thomas, S.A. et al. Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue. Br. J. Urol. 77, 367-372 (1996).
23. Triantafilou, M., Fradelizi, D. & Triantafilou, K. Major histocompatibility class one molecule associates with glucose regulated protein (GRP) 78 on the cell surface. Hum. Immunol. 62, 764-770 (2001).
24. Triantafilou, K., Fradelizi, D., Wilson, K. & Triantafilou, M. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J. Virol. 76, 633-643 (2002).
25. Rao, R.V. et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514, 122-128 (2002).
26. Tamura, Y., Peng, P., Liu, K., Daou, M. & Srivastava, P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117-120 (1997).
27. Srivastava, P.K., Kumar, S. & Mendonca, C. in Principles and Practice of Biologic Therapy of Cancer (ed. Rosenberg, S.A.) 1-13 (Lippincott Williams & Wilkins, NewYork, 2001).
28. Srivastava, P.K., Menoret, A., Basu, S., Binder, R.J. & McQuade, K.L. Heat shock proteins come of age: Primitive functions acquire new roles in an adaptive world. Immunity 8, 657-665 (1998).
29. Golub, T.R. et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
30. Dhanasekaran, S.M. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826 (2001).
31. Chen, Y.T. Cancer vaccine: Identification of human tumor antigens by SEREX. Cancer J. Sci. Am. 6, S208-S217 (2000).
32. Tureci, O., Sahin, U. & Pfreundschuh, M. Serological analysis of human tumor antigens: Molecular definition and implications. Mol. Med. Today 8, 342-9 (1997).
33. Sahin, U. et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92, 11810-11813 (1995).
34. Sioud, M. & Hansen, M.H. Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries. Eur. J. Immunol. 3, 716-725 (2001).
35. Crameri, R., Achatz, G., Weichel, M. & Rhyner, C. Direct selection of cDNAs by phage display. Methods Mol. Biol. 185, 461-469 (2002).
36. Nakatsura, T. et al. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem. Biophys. Res. Commun. 281, 936-944 (2001).
37. Kouzmitcheva, G.A., Petrenko, V.A. & Smith, G.P. Identifying diagnostic peptides for Lyme disease through epitope discovery. Clin. Diagn. Lab, Immunol. 8, 150-160 (2001).
38. Motti, C. et al. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. Gene 146, 191-198 (1994).
39. Puntoriero, G. et al. Towards a solution for hepatitis C virus hypervariability: Mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J. 17, 3521-3533 (1998).
40. Prezzi, C. et al. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156, 4504-4513 (1996).
41. Scala, G. et al. Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. J. Immunol. 162, 6155-6161 (1999).
42. Dybwad, A., Forre, O., Kjeldsen-Kragh, J., Natvig, J.B. & Sioud, M. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur. J. Immunol. 23, 3189-3193 (1993).
43. Lunardi, C. et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat. Med. 6, 1183-1186 (2000).
44. Rowley, M. J. et al. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J. Immunol. 164, 3413-3419 (2000).
45. Cortese, I. et al. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA 93, 11063-11067 (1996).
46. Mennuni, C. et al. Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes. J. Autoimmun. 9, 431-436 (1996).
47. Schroder, F.H. et al. The TNM classification of prostate cancer. Prostate 4, 129-138 (1992).
48. Gleason, D.F. in Urologic Pathology: The Prostate (ed. Tannenbaum, M.) 171-197 (Lea & Febiger, Philadelphia, PA, 1977).
49. Breiman, L., Friedman, J.H., Olshen, R.A. & Stone, C. in Classification and Regression Trees pp. 1-336 (Wadsworth International Group, Belmont, California, 1984).